Education
About Us
Working with TipRanks
Follow Us
Thyrocare Technologies Ltd (IN:THYROCARE)
:THYROCARE
THYROCARE Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹620.85 - ₹1,100.60
Previous CloseN/A
Volume114.81K
Average Volume (3M)4.78K
Market Cap
₹56.98B
Enterprise Value₹22.80B
Total Cash (Recent Filing)₹1.93B
Total Debt (Recent Filing)₹246.80M
Price to Earnings (P/E)62.2
Beta0.57
Next Earnings
Jul 30, 2025EPS EstimateN/A
Last Dividend Ex-Date
Aug 16, 2024Dividend Yield1.69%
Share Statistics
EPS (TTM)6.30
Shares Outstanding52,994,446
10 Day Avg. Volume4,017
30 Day Avg. Volume4,776
Financial Highlights & Ratios
PEG Ratio-0.56
Price to Book (P/B)4.26
Price to Sales (P/S)0.00
P/FCF Ratio26.55
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹910.00Price Target Upside18.36% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Thyrocare Technologies Ltd News
PremiumCompany Announcements
Thyrocare Confirms Compliance with SEBI Regulations for Q1 2025
PremiumCompany Announcements
Thyrocare Technologies Announces Trading Window ClosureTHYROCARE FAQ
What was Thyrocare Technologies Ltd’s price range in the past 12 months?
Thyrocare Technologies Ltd lowest stock price was ₹620.85 and its highest was ₹1100.60 in the past 12 months.
What is Thyrocare Technologies Ltd’s market cap?
Thyrocare Technologies Ltd’s market cap is ₹56.98B.
When is Thyrocare Technologies Ltd’s upcoming earnings report date?
Thyrocare Technologies Ltd’s upcoming earnings report date is Jul 30, 2025 which is in 20 days.
How were Thyrocare Technologies Ltd’s earnings last quarter?
Thyrocare Technologies Ltd released its earnings results on Apr 23, 2025. The company reported ₹6.3 earnings per share for the quarter, beating the consensus estimate of ₹4.8 by ₹1.5.
Is Thyrocare Technologies Ltd overvalued?
According to Wall Street analysts Thyrocare Technologies Ltd’s price is currently Undervalued.
Does Thyrocare Technologies Ltd pay dividends?
Thyrocare Technologies Ltd pays a Annually dividend of ₹18 which represents an annual dividend yield of 1.69%. See more information on Thyrocare Technologies Ltd dividends here
What is Thyrocare Technologies Ltd’s EPS estimate?
Thyrocare Technologies Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Thyrocare Technologies Ltd have?
Thyrocare Technologies Ltd has 52,994,446 shares outstanding.
What happened to Thyrocare Technologies Ltd’s price movement after its last earnings report?
Thyrocare Technologies Ltd reported an EPS of ₹6.3 in its last earnings report, beating expectations of ₹4.8. Following the earnings report the stock price went down -3.204%.
Which hedge fund is a major shareholder of Thyrocare Technologies Ltd?
Currently, no hedge funds are holding shares in IN:THYROCARE
Company Description
Thyrocare Technologies Ltd
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include 34 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company also sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
Technical Analysis
Krsnaa Diagnostics Limited
―
Medi Assist Healthcare Services Limited
―
Metropolis Healthcare Ltd.
―
Morepen Laboratories Limited
―
Vijaya Diagnostic Centre Ltd.
―